7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

78,064.84

+745.49

+0.96%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Nasdaq Real Time Price USD

GlucoTrack, Inc. (GCTK)

1.3900 0.0000 (0.00%)

At close: October 29 at 4:00:01 PM EDT

Loading Chart for GCTK

Chart Range Bar

Interval:

In partnership with ChartIQ

Glucotrack, Inc. Announces Reverse Stock Split

Glucotrack, Inc. Announces Reverse Stock Split

Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn

Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn

Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™

Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™

Glucotrack, Inc. Announces Pricing of $3 Million Public Offering

Glucotrack, Inc. Announces Pricing of $3 Million Public Offering

Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform

Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform

Glucotrack Announces $11.5 Million Financing

Glucotrack Announces $11.5 Million Financing

Glucotrack, Inc. Announces Reverse Stock Split

Glucotrack, Inc. Announces Reverse Stock Split

Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100

Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Mobilize your Website

View Site in Mobile | Classic

Share by: